Publications
- PCSK9 inhibitors - new possibilities in the treatment of hypercholesterolemia: For which patients will be indicated? Czech atherosclerosis society statement2016 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Endothelial dysfunction in type 1 diabetes mellitus2010 | Faculty of Medicine in Hradec Králové
- Combined hypolipidemic treatment in patients with high cardiovascular (CV) risk2009 | First Faculty of Medicine
- Hypolipidemic drugs and diabetes mellitus2009 | First Faculty of Medicine
- Clinical impact of MIAC syndrom (malnutrition, inflammation, atherosclerosis, calcification) in patients with chronic renal disease2008 | First Faculty of Medicine
- Combined hypolipidemic treatment in jpatients with high cardiovascular (CV) risk2008 | First Faculty of Medicine
- Correlation of individual parameters of MIAC syndrome (mallnutrition, inflammation, atherosclerosis and calcification) with the changes in peripheral blood flow during hemodialysis (HD) with ultrafiltration (UF) +12007 | First Faculty of Medicine
- MIAC syndrome (malnutrition, inflammation, atherosclerosis, calcification)2007 | First Faculty of Medicine
- Hypolepidemic therapy in diabetics with renal disease2007 | First Faculty of Medicine
- Fibrates in treatment of dyslipoproteinemia2006 | First Faculty of Medicine
Loading network view...